{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:00:02Z","timestamp":1780639202117,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012414","name":"Armed Forces Radiobiology Research Institute, Uniformed Services University","doi-asserted-by":"publisher","award":["10650"],"award-info":[{"award-number":["10650"]}],"id":[{"id":"10.13039\/100012414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012414","name":"Armed Forces Radiobiology Research Institute, Uniformed Services University","doi-asserted-by":"publisher","award":["12080"],"award-info":[{"award-number":["12080"]}],"id":[{"id":"10.13039\/100012414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012414","name":"Armed Forces Radiobiology Research Institute, Uniformed Services University","doi-asserted-by":"publisher","award":["13586"],"award-info":[{"award-number":["13586"]}],"id":[{"id":"10.13039\/100012414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.drudis.2025.104502","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:30:17Z","timestamp":1760164217000},"page":"104502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-3849","authenticated-orcid":false,"given":"Vijay K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Machlenkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Seed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104502_b0005","first-page":"9","article-title":"Health risks from high-level radiation exposures from radiological weapons","volume":"21","author":"Scott","year":"2004","journal-title":"Radiat Protect Manage"},{"key":"10.1016\/j.drudis.2025.104502_b0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/09553002.2017.1332438","article-title":"A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures","volume":"93","author":"Singh","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.drudis.2025.104502_b0015","series-title":"Radiobiology for the Radiobiologist","author":"Hall","year":"2012"},{"key":"10.1016\/j.drudis.2025.104502_b0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/dmp.2011.68","article-title":"First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation","volume":"5","author":"Dainiak","year":"2011","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.drudis.2025.104502_b0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1259\/bjr\/25654769","article-title":"Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research","volume":"27","author":"Meineke","year":"2005","journal-title":"Br J Radiol Suppl"},{"key":"10.1016\/j.drudis.2025.104502_b0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1259\/bjr\/18309193","article-title":"Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system","volume":"27","author":"Moulder","year":"2005","journal-title":"Br J Radiol Suppl"},{"key":"10.1016\/j.drudis.2025.104502_b0035","first-page":"121","article-title":"Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells","volume":"1846","author":"Heylmann","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2025.104502_b0040","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/stem.16","article-title":"Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S.\/European Consultation Workshop","volume":"27","author":"Fliedner","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2025.104502_b0045","series-title":"Assessing Medical Preparedness to Respond to a Terrorist Nuclear Event: Workshop Report","author":"Institute of Medicine","year":"2009"},{"key":"10.1016\/j.drudis.2025.104502_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1667\/RR3283","article-title":"Radiological\/Nuclear Threat Countermeasures Working Group. Priority list of research areas for radiological nuclear threat countermeasures","volume":"163","author":"Pellmar","year":"2005","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0055","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMsr1714289","article-title":"Are we prepared for nuclear terrorism?","volume":"378","author":"Gale","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104502_b0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/antiox5030022","article-title":"Protection against radiotherapy-induced toxicity","volume":"5","author":"Hall","year":"2016","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.drudis.2025.104502_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1269\/jrr.42.21","article-title":"Radioprotectors in radiotherapy","volume":"42","author":"Nair","year":"2001","journal-title":"J Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0070","first-page":"105","article-title":"Looking on the horizon; potential and unique approaches to developing radiation countermeasures for deep space travel","volume":"35","author":"Bokhari","year":"2022","journal-title":"Life Sci Space Res (Amst)"},{"key":"10.1016\/j.drudis.2025.104502_b0075","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1667\/RR3276","article-title":"Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3\u20134, 2003","volume":"162","author":"Stone","year":"2004","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1667\/RR2783.1","article-title":"Efficacy of radiation countermeasures depends on radiation quality","volume":"177","author":"Cary","year":"2012","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0085","series-title":"Chronic Irradiation: Tolerance and Failure in Complex Biological Systems","first-page":"103","article-title":"The influence of dose, dose rate and radiation quality on the effect of protracted whole body irradiation of beagle","author":"Fritz","year":"2002"},{"key":"10.1016\/j.drudis.2025.104502_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.icrp.2012.02.001","article-title":"ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs\u2014threshold doses for tissue reactions in a radiation protection context","volume":"41","author":"Stewart","year":"2012","journal-title":"Ann ICRP"},{"key":"10.1016\/j.drudis.2025.104502_b0095","first-page":"13","article-title":"Radiation poisoning: current concepts in the acute radiation syndrome","volume":"3","author":"McCann","year":"2006","journal-title":"Am J Clin Med"},{"key":"10.1016\/j.drudis.2025.104502_b0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1358\/dot.2015.51.9.2386730","article-title":"Filgrastim for the treatment of hematopoietic acute radiation syndrome","volume":"51","author":"Farese","year":"2015","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.drudis.2025.104502_b0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1358\/dot.2018.54.11.2899370","article-title":"An update on sargramostim for treatment of acute radiation syndrome","volume":"54","author":"Singh","year":"2018","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.drudis.2025.104502_b0110","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/09553002.2021.1969054","article-title":"Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond","volume":"97","author":"Singh","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.drudis.2025.104502_b0115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1667\/RR13940.1","article-title":"Pegfilgrastim improves survival of lethally irradiated nonhuman primates","volume":"183","author":"Hankey","year":"2015","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0120","first-page":"191","article-title":"Sargramostim (rhu GM-CSF) improves survival of non-human primates with severe bone marrow suppression after acute, high-dose, whole-body irradiation","volume":"195","author":"Clayton","year":"2021","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0125","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1080\/09553002.2019.1673499","article-title":"Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model","volume":"97","author":"Zhong","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.drudis.2025.104502_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dot.2022.58.3.3367994","article-title":"An update on romiplostim for treatment of acute radiation syndrome","volume":"58","author":"Singh","year":"2022","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.drudis.2025.104502_b0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1667\/RR3049.1","article-title":"Filgrastim improves survival in lethally irradiated nonhuman primates","volume":"179","author":"Farese","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0140","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/14712598.2022.2143261","article-title":"Sargramostim in acute radiation syndrome","volume":"22","author":"Lazarus","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.drudis.2025.104502_b0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09553002.2019.1625488","article-title":"Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates","volume":"96","author":"Wong","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.drudis.2025.104502_b0150","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ijrobp.2023.05.008","article-title":"Survival and hematologic benefits of romiplostim after acute radiation exposure supported FDA approval under the animal rule","volume":"117","author":"Bunin","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.drudis.2025.104502_b0155","unstructured":"U.S. Food and Drug Administration. Radiological and Nuclear Emergency Preparedness. www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/radiological-and-nuclear-emergency-preparedness-information-fda. Accessed November 7, 2024."},{"key":"10.1016\/j.drudis.2025.104502_b0160","unstructured":"U.S. Food and Drug Administration. Animal Rule Approvals. www.fda.gov\/drugs\/nda-and-bla-approvals\/animal-rule-approvals. Updated October 30, 2024. Accessed December 5, 2024."},{"key":"10.1016\/j.drudis.2025.104502_b0165","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/09553002.2017.1338782","volume":"93","author":"Singh","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.drudis.2025.104502_b0170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/09553002.2017.1332440","volume":"93","author":"Singh","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.drudis.2025.104502_b0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13543784.2023.2169127","article-title":"Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives","volume":"32","author":"Singh","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.drudis.2025.104502_b0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13543784.2020.1757648","article-title":"BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure","volume":"29","author":"Singh","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.drudis.2025.104502_b0185","unstructured":"U.S. Food and Drug Administration. Product Development Under the Animal Rule. Guidance Document. www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm399217.pdf. Published October 2015. Accessed October 20, 2022."},{"key":"10.1016\/j.drudis.2025.104502_b0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40778-020-00176-0","article-title":"Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome","volume":"6","author":"Chinnadurai","year":"2020","journal-title":"Curr Stem Cell Rep"},{"key":"10.1016\/j.drudis.2025.104502_b0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/cells9010127","article-title":"Mesenchymal stromal cells from fetal and maternal placenta possess key similarities and differences: potential implications for their applications in regenerative medicine","volume":"9","author":"Papait","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104502_b0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fmed.2018.00037","article-title":"Posttransplant intramuscular injection of PLX-R18 mesenchymal-like adherent stromal cells improves human hematopoietic engraftment in a murine transplant model","volume":"5","author":"Metheny","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.drudis.2025.104502_b0205","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41409-023-02068-3","article-title":"Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: a phase I study","volume":"58","author":"McGuirk","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.drudis.2025.104502_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066549","article-title":"Mitigation of lethal radiation syndrome in mice by intramuscular injection of 3D cultured adherent human placental stromal cells","volume":"8","author":"Gaberman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104502_b0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood-2020-138662","article-title":"Safety and demonstrated efficacy of placenta-derived cell therapy PLX-R18 in subjects with icomplete hematopoietic recovery following hematopoietic cell transplantation: a phase I international multi-center study","volume":"136","author":"Lazarus","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2025.104502_b0220","unstructured":"Ofir R. Prophylactic administration of placenta-derived PLX-R18 stromal cells mitigates H-ARS death and promotes BM and peripheral blood lineage recovery in a murine model. Abstract. 2019 Radiation Injury Treatment Network (RITN) Workshop. July 30\u201331, 2019. Arlington, VA. https:\/\/ritn.net\/-\/media\/project\/nmdp\/ritn\/documents\/events\/workshops\/2019\/ritn-workshop-packet-crisis-in-context-gaps-medical-preparedness-2019-july.pdf?rev=45561133bf5f49a9869983179d0d3da4&hash=8D58CF1C0F896A226CB01140015F7A39."},{"key":"10.1016\/j.drudis.2025.104502_b0225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0963689717727543","article-title":"Placenta-derived adherent stromal cell therapy for hematopoietic disorders: a case study of PLX-R18","volume":"27","author":"Sher","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.drudis.2025.104502_b0230","unstructured":"Pluri Biotech Ltd. Cell Based Solutions at Scale. https:\/\/pluri-biotech.com\/. 2025, Accessed March 30, 2025."},{"key":"10.1016\/j.drudis.2025.104502_b0235","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/jcsm.12342","article-title":"Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells","volume":"9","author":"Pinzur","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.drudis.2025.104502_b0240","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/genes13101756","article-title":"Pre-administration of PLX-R18 cells protects mice from radiation-induced hematopoietic failure and lethality","volume":"13","author":"Kumar","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.drudis.2025.104502_b0245","first-page":"3784","article-title":"Intramuscular administration of placenta-derived stromal cells enhances survival of rhesus macaque monkeys exposed to total-body irradiation","volume":"130","author":"Sher","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2025.104502_b0250","unstructured":"Pluri Biotech Ltd. PLX-R18: A Potential Treatment for Acute Radiation Syndrome. https:\/\/pluri-biotech.com\/plxr18-ars\/. Published 2025. Accessed August 29, 2025."},{"key":"10.1016\/j.drudis.2025.104502_b0255","first-page":"696","article-title":"Procalcitonin as a marker of the systemic inflammatory response to infection [in Lithuanian]","volume":"40","author":"Reingardiene","year":"2004","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.drudis.2025.104502_b0260","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/HP.0000000000000094","article-title":"Early-response biomarkers for assessment of radiation exposure in a mouse total-body irradiation model","volume":"106","author":"Ossetrova","year":"2014","journal-title":"Health Phys"},{"key":"10.1016\/j.drudis.2025.104502_b0265","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1269\/jrr.43.S209","article-title":"Role of p53 gene in apoptotic repair of genotoxic tissue damage in mice","volume":"43","author":"Kato","year":"2002","journal-title":"J Radiat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(95)00214-8","article-title":"Radiation-induced apoptosis: relevance to radiotherapy","volume":"33","author":"Dewey","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.drudis.2025.104502_b0275","first-page":"311","article-title":"Apoptotic repair of genotoxic tissue damage and the role of p53 gene","volume":"402","author":"Kondo","year":"1998","journal-title":"Mutat Res"},{"key":"10.1016\/j.drudis.2025.104502_b0280","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1172\/JCI22218","article-title":"Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation","volume":"114","author":"Tessner","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104502_b0285","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41409-024-02469-y","article-title":"Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: a phase I study","volume":"60","author":"McGuirk","year":"2025","journal-title":"Bone Marrow Transplant"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:03:53Z","timestamp":1780635833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625002156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1359644625002156"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104502","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104502"}}